Entry Port Selection for Detecting Particle Size Differences in Metered Dose Inhaler Formulations Using Cascade Impaction

Drug Development and Industrial Pharmacy

Volumn 30, Issue 1, 2004, Pages 75-82

  Naini, Venkatesh ^a   Chaudhry, Saeed ^a   Berry, Julianne ^a   Sharpe, Stefan ^a   Hart, John ^a   Sequeira, Joel ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Cascade impaction; Entry port; Metered dose inhaler (MDI)

Indexed keywords

BECLOMETASONE DIPROPIONATE; FLUORINATED HYDROCARBON;

AEROSOL; ARTICLE; CASCADE IMPACTION; COMPARATIVE STUDY; DRUG FORMULATION; DRUG MANUFACTURE; DRUG STABILITY; EQUIPMENT; FILTER; IMPACTOR; MEDICAL LITERATURE; METERED DOSE INHALER; PARTICLE SIZE; PORT OF ENTRY; TECHNIQUE;

AEROSOLS; ANTI-INFLAMMATORY AGENTS; BECLOMETHASONE; CHEMISTRY, PHARMACEUTICAL; CHLOROFLUOROCARBONS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE;

EID: 1242343613     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-120027514     Document Type: Article

References (14)

1. Mitchell, J.P.; Nagel, M.W. Medical aerosols: techniques for particle size evaluation. Part. Sci. Technol. 1997, 15, 217-241.
2. Tzou, T.-Z. Aerodynamic particle size of metered-dose inhalers determined by the quartz crystal microbalance and the Andersen cascade impactor. Int. J. Pharm. 1999, 186, 71-79.
3. LeBelle, M.J.; Graham, S.J.; Ormsby, E.D.; Duhaime, R.M.; Lawrence, R.C. ; Pike, R.K. Metered dose inhalers. II. Particle size measurement variation. Int. J. Pharm. 1997, 151, 209-221.
4. Hickey, A.J. Sampling inlet considerations in inertial particle-size analysis of inhalation aerosols. Pharm. Technol. 1995, 3, 58-67.
5. Olsson, B.; Borgstrom, L.; Asking, L.; Bondesson, E. Effect of inlet throat on the correlation between measured fine particle dose and lung deposition. In Respiratory Drug Delivery V; Dalby, R.N., Byron, P.R., Farr, S.J., Eds.; Interpharm Press: Buffalo Grove, IL, 1996; 273-281.
6. Stein, S.W.; Gabrio, B.J. Understanding throat deposition during cascade impactor testing. In Respiratory Drug Delivery VII; Byron, P.R., Dalby, R.N., Peart, J., Farr, S.J., Eds.; DHI Publishing: Raleigh, NC, 2000; 287-290.
7. Velasquez, D.J.; Gabrio, B. Metered dose inhaler aerosol deposition in a model of the human respiratory system and a comparison with clinical deposition studies. J. Aerosol Med. 1998, 11 (Suppl. 1), S23-S28.
8. USP25-NF20. In 〈601〉 General Chapter on Aerosols; United States Pharmacopeial Convention; Rockville, MD, 2002; 1964-1980.
9. Graham, S.J.; Lawrence, R.C.; Ormsby, E.D.; Pike, R.K. Particle size distribution of single and multiple sprays of salbutamol metered dose inhalers (MDIs). Pharm. Res. 1995, 12, 1380-1384.
10. Impaq-6 Operating Manual; California Measurements: Sierra Madre, CA.
11. European Pharmacopoeia. Apparatus A (Glass Impinger); 1997.
12. Van Oort, M.; Gollmar, R.O.; Bohinski, R.J. Effects of chamber volume and geometry on aero-dynamic size distributions of metered dose inhalation aerosols measured using cascade impactor. Pharm. Res. 1994, 11, 604-607.
13. Midoux, N.; Hosek, P.; Pailleres, L.; Authelin, J.R. Micronization of pharmaceutical substances in a spiral jet mill. Powder Technol. 1999, 104, 113-120.
14. Phillips, E.M.; Byron, P.R. Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonfluoromethane. Int. J. Pharm. 1994, 110, 9-19.